about
Cardiovascular disease in systemic sclerosis--an emerging association?MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblastsDigital ulcers in systemic sclerosisRaynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and managementA critical view on cardiovascular risk in systemic sclerosis.Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.Cardiovascular involvement in autoimmune diseases.Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolCardiac manifestations in systemic sclerosis.Development of agents for the treatment of systemic sclerosis.Cardiovascular disease in systemic sclerosis.Dyslipidaemia in rheumatological autoimmune diseasesAtherosclerosis in systemic sclerosis: a systematic review and meta-analysisThe risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease.Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factorsLack of evidence for bacterial infections in skin in patients with systemic sclerosis.Atherosclerosis in Systemic Sclerosis: a Modern Controversy.Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study.The pathogenesis, diagnosis and treatment of Raynaud phenomenon.Scleroderma therapy: clinical overview of current trends and future perspective.A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis.Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis.Early morphologic and functional changes of atherosclerosis in systemic sclerosis-a systematic review and meta-analysis.Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis.Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.A longitudinal study of ankle brachial pressure indices in a cohort of patients with systemic sclerosis.No association of atherosclerosis with digital ulcers in Japanese patients with systemic sclerosis: evaluation of carotid intima-media thickness and plaque characteristics.Subclinical atherosclerosis in scleroderma patients.Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis.Early identification of vascular damage in patients with systemic sclerosis.Foot health needs in people with systemic sclerosis: an audit of foot health care provision.
P2860
Q21195262-B721F947-D531-4876-99D0-61B3F4266553Q24802883-FC883899-9F4B-4367-9B83-271D315E6C59Q28080196-8283DE8F-CADF-427E-A882-9327CD6F8756Q28392431-45FF52A2-C54E-4965-B798-0B41C03FB920Q30249024-E0F3FC4F-867F-4A50-8E50-EA5D0F17DCE9Q33923465-A969338E-AE7F-48DD-8670-BBF436DCD514Q34081242-61692DD7-C81F-439E-85EB-F7BAB7D6D8F8Q34152046-6932C4DA-C6B8-4FFD-8274-F635CA52075DQ34251904-41C525CB-05BE-40EC-B63E-1D3AB780A080Q34481552-89CDE0B8-16B1-4E37-A2D7-3418AE97698CQ34947193-12DEBDB3-4A6E-40F3-BE39-6EF26BBF65EBQ35029916-0428919F-8D38-453F-9A25-3FEB579671B5Q35082399-62856393-A2D2-4AC1-A23A-85E7E51B4759Q35283742-471F865F-4788-48EA-A5E1-AEBFAD8A17CEQ36401844-B77DB085-04AF-4460-9D09-42D718ECED99Q36757042-5362A74D-535B-476C-A3C3-036E1E5CA4EDQ37356850-2EB9BA4C-66FC-47BA-A007-1DDE2104523FQ37668990-4B0FC5FC-EDF9-448D-874A-F9F524E41B74Q37690605-24211858-02BB-4753-AC40-6EDDFA156515Q37690928-03E9E6E2-F156-4EEE-AD11-361379E84F2EQ38025285-226091F1-6F6A-4DCA-A44F-60BBF3514723Q38046467-F2D308A0-0BAA-485D-9486-C1E1006F5E11Q38425913-96221A34-582B-4AA3-8EC5-0FC1B3D0EB0AQ38446736-3E3877E7-6431-4BA7-8AA5-88D4E4A5841FQ38937968-0DED601A-482B-40A9-9125-988B997C15EAQ39774910-10EE930A-0A98-4F07-A6FE-AF241475CAA7Q39977068-C90353BF-3FEA-45FB-B70F-DB075956590DQ40198680-9FAE6380-7AED-488B-8B1B-3F0A55E15B36Q40201236-C27CA1F2-6AFA-4E72-B2CC-6B49E6674628Q43061735-CC3E8ABD-CBF9-4D5A-8E4E-28BC73663260Q46313908-F1F24F5F-56AC-4396-A419-62ACBB31DB6EQ48237153-44D25ED3-249D-452D-B13C-25A6A060C1E4Q50683587-8EA3DD29-DFE7-4F6C-9F88-A8A02B64CEF4Q52845511-FE9A14EC-0956-46E5-BE6C-CB862DA49F6F
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Macrovascular disease and systemic sclerosis.
@ast
Macrovascular disease and systemic sclerosis.
@en
type
label
Macrovascular disease and systemic sclerosis.
@ast
Macrovascular disease and systemic sclerosis.
@en
prefLabel
Macrovascular disease and systemic sclerosis.
@ast
Macrovascular disease and systemic sclerosis.
@en
P2093
P2860
P356
P1476
Macrovascular disease and systemic sclerosis.
@en
P2093
P2860
P356
10.1136/ARD.59.1.39
P407
P577
2000-01-01T00:00:00Z